Danaher (NYSE:DHR) Releases FY 2025 Earnings Guidance

Danaher (NYSE:DHR) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 7.700-7.800 for the period, compared to the consensus estimate of 7.770. The company issued revenue guidance of -.

Danaher Stock Performance

Shares of NYSE DHR opened at $221.13 on Wednesday. The firm’s 50-day moving average price is $202.07 and its 200-day moving average price is $197.59. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a market cap of $158.34 billion, a PE ratio of 47.05, a PEG ratio of 3.01 and a beta of 0.77. Danaher has a 52-week low of $171.00 and a 52-week high of $269.24.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts anticipate that Danaher will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a report on Wednesday, October 8th. Robert W. Baird raised their price objective on shares of Danaher from $229.00 to $236.00 and gave the stock an “outperform” rating in a report on Wednesday, October 15th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a report on Tuesday, September 2nd. Evercore ISI raised their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Finally, Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $245.00.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.20% of the company’s stock.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently modified their holdings of the stock. WFA of San Diego LLC bought a new stake in Danaher in the second quarter worth $26,000. Zuckerman Investment Group LLC bought a new stake in Danaher in the second quarter worth $222,000. Gallagher Fiduciary Advisors LLC increased its position in Danaher by 7.5% in the second quarter. Gallagher Fiduciary Advisors LLC now owns 1,149 shares of the conglomerate’s stock worth $227,000 after purchasing an additional 80 shares during the last quarter. 44 Wealth Management LLC increased its position in Danaher by 7.8% in the second quarter. 44 Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $250,000 after purchasing an additional 92 shares during the last quarter. Finally, HUB Investment Partners LLC increased its position in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock worth $273,000 after purchasing an additional 325 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.